Article List

POPULAR ARTICLES

  • Opening the Door to Regenerative Medicine: iPS Cardiac Muscle Sheets

    On April 8, 2025, Japan’s regenerative medicine reached a historic turning point. Cuorips Inc., a biotech venture spun out of Osaka University, announced it had submitted a marketing authorization application to Japan’s Ministry of Health, Labour and Welfare (MHLW) for a “cardiomyocyte sheet” created from human induced pluripotent stem (iPS) cells. This is believed to be the world’s first marketing application aiming to commercialize a regenerative medicine product using iPS cells, and it has generated great anticipation across the scientific and medical communities.

    By Honourway Asia Pacific Limited